SITAVIG

This brand name is authorized in France, United States

Active ingredients

The drug SITAVIG contains one active pharmaceutical ingredient (API):

1 Aciclovir UNII X4HES1O11F - ACYCLOVIR

Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation. Read about Aciclovir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SITAVIG Delayed-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AB01	Aciclovir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 63247409
Country: US	FDA, National Drug Code	Identifier(s): 71403-049